Loading…
Loading…
EQUITY / NASDAQ · XNCM
ENDRA Life Sciences Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗6.06 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 6.06 USD · Volume 39,801
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Operating profit | -1,483,256 USD | — | — |
| Net income | 159,944 USD | — | — |
| Cash and cash equivalents | 1,739,943 USD | — | — |
| Total liabilities | 1,632,514 USD | — | — |
| Total equity | 6,309,691 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 203/31/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 101/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,739,943 USD | — | — | — | 762,365 USD | — | — | — |
| Net incomeIncome statement | 159,944 USD | -1,151,489 USD | — | -1,311,433 USD | — | -7,027,410 USD | -1,595,959 USD | -3,858,201 USD |
| Operating profitIncome statement | -1,483,256 USD | -3,657,004 USD | — | -2,173,748 USD | — | -5,763,101 USD | -1,370,703 USD | -4,141,075 USD |
| Total assetsBalance sheet | 7,942,205 USD | — | — | 3,438,182 USD | 3,853,797 USD | 3,853,797 USD | 1,964,108 USD | — |
| Total equityBalance sheet | 6,309,691 USD | — | 1,786,885 USD | 1,786,885 USD | 2,260,120 USD | 2,260,120 USD | 171,380 USD | — |
| Total liabilitiesBalance sheet | 1,632,514 USD | — | — | 1,651,297 USD | 1,593,677 USD | 1,593,677 USD | 1,792,728 USD | — |
| Capital expendituresCash flow statement | — | 18,670 USD | — | — | — | 17,280 USD | — | 17,280 USD |
| Financing cash flowCash flow statement | — | 4,157,686 USD | — | 263,747 USD | — | 5,732,723 USD | — | 1,152,684 USD |
| Investing cash flowCash flow statement | — | 2,667,105 USD | — | 450,000 USD | — | -3,017,280 USD | — | -17,280 USD |
| Operating cash flowCash flow statement | — | -2,047,210 USD | — | -1,119,650 USD | — | -5,182,558 USD | — | -3,570,847 USD |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.